BIOPLUS INTERPHEX Korea 2025 x KACTUS

By Hannah Flaherty

September 24, 2025

Menu

What are BioPlus and Interphex?

BIOPLUS-INTERPHEX Korea is a leading exhibition that brings together global biopharmaceutical professionals to explore the latest advances in drug development and manufacturing. The event covers the entire value chain, including biopharma R&D, process development, manufacturing technologies, quality control, digital health, packaging, and cold-chain logistics. With its combination of large-scale exhibition, international conference sessions, and partnering programs, BIOPLUS-INTERPHEX Korea serves as a comprehensive hub for innovation, collaboration, and business development in the global bio-industry.

Event Overview

Venue: COEX, Hall C (3F) & Conference Rooms, Seoul, Korea

Dates: October 15th to 17th 2025

Conference Day 1: Wednesday, October 15, 2025 – 9:30 AM to 4:45 PM
Conference Day 2: Thursday, October 16, 2025 – 9:00 AM to 4:45 PM
Conference Day 3: Friday, October 17, 2025 – 9:00 AM to 3:15 PM

Booth #F06

Event Schedule

BIX highlights the latest innovations in biopharmaceuticals. Over three days at COEX Seoul, the event delivers keynote talks, technical sessions, and networking focused on drug discovery, manufacturing, quality control, digital health, and regenerative medicine. Explore the full agenda to see what’s ahead.

Day 1: Wednesday, October 15, 2025

Time	Session Type	Title
9:00 – 9:30 AM	Registration	Registration
9:30 – 10:00 AM	Opening Ceremony	Opening Ceremony
10:15 – 10:45 AM	Keynote Session	The Role of Cellular and Regenerative Medicine in Longevity and Human Performance
11:00 – 12:00 PM	Technical Session 01	Ready to Jump Off the Patent Cliff? A Global Perspective on Biopharma’s Hunt for the Next Blockbusters
11:00 – 12:00 PM	Technical Session 02	How FDA’s New Rules Are Reshaping the Future of Global Biotech
12:00 – 1:00 PM	Luncheon Session 01	Luncheon Session
1:00 – 2:00 PM	Technical Session 03	Anti-Aging: The Next Bio Frontier? Challenges and Strategies in Science, Regulation, and the Market
1:00 – 2:00 PM	Technical Session 04	Biotech’s ESG Disclosure Gap: How Prepared Are We?
2:15 – 2:45 PM	Insight Session 01	Insight on Regulatory Innovation
2:15 – 2:45 PM	Insight Session 02	Insight on Regulatory Pathways
3:00 – 3:30 PM	Insight Session 03	Insight on Clinical Data and Real-World Evidence
3:00 – 3:30 PM	Insight Session 04	Insight on Global Regulatory Trends
3:45 – 4:45 PM	Technical Session 05	NewCo: Just a Spin-Off or an Innovative Business Structure?
3:45 – 4:45 PM	Technical Session 06	Building Cross-Border Commercialization Pathways

Day 2: Thursday, October 16, 2025

Time	Session Type	Title
9:00 – 10:00 AM	Featured Session	The Transformation of Health by Technology
9:00 – 10:00 AM	Technical Session 07	Next-Generation WhiteBio Business Model: Carbon Circulation Platform
9:00 – 10:00 AM	Technical Session 08	US Industry Insights for Korea’s Global Leap
10:15 – 10:45 AM	Insight Session 05	Technology Insight
10:15 – 10:45 AM	Insight Session 06	Technology Innovation
11:00 – 12:00 PM	Technical Session 09	Accelerating ADC Globalization: Trends, Challenges, and Strategic Collaborations
11:00 – 12:00 PM	Technical Session 10	Innovation Driven Drug Discovery in Real Fields
12:00 – 1:00 PM	Luncheon Session 02	Luncheon Session
1:00 – 2:00 PM	Technical Session 11	Radiopharma Revolution: Unmet Needs, Innovation, and Global Access
1:00 – 2:00 PM	Technical Session 12	Global Pharma Cold Chain Innovation: GDP Compliance and Sustainable Logistics
2:15 – 2:45 PM	Insight Session 07	Technology Breakthroughs in Biopharma
2:15 – 2:45 PM	Insight Session 08	Technology for Next-Gen Biologics
3:00 – 3:30 PM	Insight Session 09	Technology Strategies for Global Expansion
3:00 – 3:30 PM	Insight Session 10	Technology Solutions for Bio Logistics
3:45 – 4:45 PM	Insight Session 11	KOSDAQ Listing Strategies for Bio Companies: Deep Dive into Special Technology Listing Track
3:45 – 4:45 PM	Technical Session 13	Connecting the Korea-Japan Bio Ecosystem: Strategies for Open Innovation

Day 3: Friday, October 17, 2025

Time	Session Type	Title
9:00 – 10:00 AM	Technical Session 14	China Biotech’s “Deepseek” Moment Is Coming. Are You Ready?
9:00 – 10:00 AM	Technical Session 15	Navigating Future Growth through Biotech M&A
10:15 – 10:45 AM	Insight Session 12	Global Biotech Manufacturing Trends
11:00 – 12:00 PM	Technical Session 16	Emerging Trends in Bio Materials, Equipment, Cold Chain, and AI Applications
12:00 – 1:50 PM	Docent Tour	New Drug Development, Cold Chain, and Lab Equipment
2:15 – 3:15 PM	Technical Session 17	Licensing-Out Strategies for K-Bio: Unlocking Global Opportunities

About KACTUS

KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 2500 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.